STREAM

Incomplete

Armstrong PW, et al. "Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction". NEJM. 2013. 368(15):1379-87.
PubMed • PDF • ClinicalTrials.gov

Guidelines

As of June 2018, no guidelines have been published that reflect the results of this trial.

Design

• Multicenter, open-label, parallel-group, randomized, controlled trial
• N=
  • Intervention (n=)
  • Placebo (n=)
• Setting:
• Enrollment:
• Mean follow-up:
• Analysis:
• Primary Outcome: 30-day composite of death from any cause, shock, congestive heart failure, or reinfarction

Population

Baseline Characteristics

BLANK Group displayed

• Demographics:
• Physiologic parameters:
• Anthropomorphics: Weight
• Labs:
• Site of infection

Outcomes

Comparisons are BLANK therapy vs. BLANK therapy.